Physician
Above Urgent Care Center
Above Urgent Care Center was paid $1.97M by Medicaid between Apr 2019 and Nov 2024, across 43 billing codes. Its largest line is 99205, Prolong outpt/office vis — 33% of everything it billed.
33Billing provider infoABOVE URGENT CARE CENTER
MONTCLAIR, CA 91763
MONTCLAIR, CA 91763
33aNPI1215498811assigned 03/27/2019
33bProvider typeEmergency Medicine Physician
28Total paid$1.97M
24GClaims62,326
24DCodes billed43
24AFirst – last monthApr 2019 – Nov 2024
Compared with peers
Next to other Emergency Medicine Physician providers in California
Rank by total paid#185 of 988
Median peer was paid$32K
This provider vs. median62×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 9,738 | $309K | |
| 2020 | 13,696 | $442K | |
| 2021 | 13,147 | $549K | |
| 2022 | 9,761 | $173K | |
| 2023 | 8,925 | $225K | |
| 2024incomplete | 7,059 | $268K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99205 | Prolong outpt/office vis | 33% | 8,737 | 8,692 | $650K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 20% | 7,211 | 6,427 | $399K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 14% | 5,539 | 5,387 | $283K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 9.8% | 3,984 | 3,964 | $192K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.7% | 8,380 | 7,796 | $192K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.2% | 3,475 | 3,231 | $103K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.9% | 1,115 | 1,111 | $38K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.9% | 2,073 | 1,843 | $38K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.3% | 4,029 | 3,905 | $25K |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | <1% | 2,979 | 2,809 | $9K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,165 | 1,650 | $8K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 3,386 | 3,044 | $7K |
31 more codes
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 261 | $3K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 299 | $3K |
| 99072 | <1% | 1,156 | $3K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 169 | $3K |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 169 | $2K |
| 99401 | <1% | 1,469 | $2K | |
| 81003 | <1% | 2,139 | $2K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 441 | $1K |
| 86328 | <1% | 113 | $1K | |
| 86769 | <1% | 113 | $968.99 | |
| 99051 | <1% | 255 | $550.71 | |
| 96127 | <1% | 202 | $401.87 | |
| 99070 | <1% | 104 | $278.01 | |
| 99000 | <1% | 540 | $242.34 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 299 | $237.09 |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source | <1% | 49 | $203.68 |
| 86635 | <1% | 58 | $142.20 | |
| A9150 | Non-prescription drugs | <1% | 55 | $81.16 |
| J3490 | Unclassified drugs | <1% | 275 | $70.19 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 85 | $46.36 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 94 | $41.50 |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 98 | $40.97 |
| 81002 | <1% | 214 | $36.35 | |
| 82948 | <1% | 81 | $31.65 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 128 | $7.19 |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 224 | $4.77 |
| 81000 | 0% | 62 | $0.00 | |
| 85018 | 0% | 30 | $0.00 | |
| 99173 | 0% | 39 | $0.00 | |
| A4550 | Surgical trays | 0% | 15 | $0.00 |
| 81025 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialVO, DAN (CEO)